Sajida Babar
Institute of Pathology and Genetics(BE)Centre Hospitalier Universitaire de Tivoli(BE)
Publications by Year
Research Areas
Neutrophil, Myeloperoxidase and Oxidative Mechanisms, Nitric Oxide and Endothelin Effects, Vanadium and Halogenation Chemistry, Synthesis and biological activity, Peripheral Artery Disease Management
Most-Cited Works
- → Triggering of inflammatory response by myeloperoxidase-oxidized LDLAn oral presentation of the data was given before the Congress of the Beligian Society of Internal Medicine.(2006)51 cited
- → Thiol-containing molecules interact with the myeloperoxidase/H2O2/chloride system to inhibit LDL oxidation(2005)48 cited
- → Neuraminidase alters red blood cells in sepsis(2009)37 cited
- → Inhibition of the myeloperoxidase chlorinating activity by non-steroidal anti-inflammatory drugs: Flufenamic acid and its 5-chloro-derivative directly interact with a recombinant human myeloperoxidase to inhibit the synthesis of hypochlorous acid(2007)36 cited
- → Effects of Phosphodiesterase Inhibitors on the Inflammatory Response of Endothelial Cells Stimulated by Myeloperoxidase-Modified Low-Density Lipoprotein or Tumor Necrosis Factor Alpha(2009)35 cited
- → Conception of myeloperoxidase inhibitors derived from flufenamic acid by computational docking and structure modification(2007)24 cited
- → Captopril inhibits the oxidative modification of apolipoprotein B-100 caused by myeloperoxydase in a comparative in vitro assay of angiotensin converting enzyme inhibitors(2006)15 cited
- → Coronary stenting is associated with an acute increase in plasma myeloperoxidase in stable angina patients but not in patients with acute myocardial infarction(2009)14 cited
- → Development and validation of a screening procedure for the assessment of inhibition using a recombinant enzyme(2007)10 cited
- → Probucol Does not Inhibit Myeloperoxidase-Dependent Low-Density Lipoprotein Oxidation as a Potent Protective Effect in Atherosclerosis(2007)4 cited